Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer

We quantified human epidermal growth factor receptor 2 (HER2) RNA and protein expression in 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) in situ hybridization (ISH) group 4 (HER2/centromeric probe 17 (CEP17) ratio <2.0, average HER2 copy number ≥4.0 and &...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Swati, Neumeister, Veronique, McGuire, John, Song, Yan S., Acs, Balazs, Ho, Kenneth, Weidler, Jodi, Wong, Wendy, Rhees, Brian, Bates, Michael, Rimm, David L., Bossuyt, Veerle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715641/
https://www.ncbi.nlm.nih.gov/pubmed/31482108
http://dx.doi.org/10.1038/s41523-019-0122-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715641/
https://www.ncbi.nlm.nih.gov/pubmed/31482108
http://dx.doi.org/10.1038/s41523-019-0122-x

Ejemplares similares